granisetron and Acute Myelogenous Leukemia

granisetron has been researched along with Acute Myelogenous Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piccioni, AL1
Goto, T; Ishibashi, M; Okamura, S; Tanimoto, K1

Other Studies

2 other study(ies) available for granisetron and Acute Myelogenous Leukemia

ArticleYear
[Out-patient management of nausea and vomiting in multiday therapy of acute myeloid leukemia in the elderly. Use of granisetron in slow-release transdermal formulation. Clinical case].
    Recenti progressi in medicina, 2019, Volume: 110, Issue:3

    Topics: Ambulatory Care; Antiemetics; Antineoplastic Agents; Delayed-Action Preparations; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Middle Aged; Nausea; Quality of Life; Vomiting

2019
[Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Cytarabine; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Retrospective Studies; Vomiting; Young Adult

2012